Aberrant methylation of GATA_3, IL-4, and TGF-β promoters may participate in BD by regulating T-cell differentiation, but whether it may become a potential biomarker for the disease remains to be further studied (Zhu et al., 2017). This evidence concerns the gene TGFB1 and Behcet disease.